Shasun Pharma to invest in capacity expansion across IndiaIllustrative image – not actual.
Shasun Pharmaceuticals is planning to invest Rs 100 crore to expand capacity of its existing product portfolio by 2013.
 
The company will raise $6 million (approx Rs 26.7 crore) through ECB to fund the expansion, while the rest of the investment is to be funded through internal accruals. Of the total capex, the company has already invested Rs 40 crore. The company has API and formulation facilities in Puducherry, biotech facility in Velacherry, Tamil Nadu and an upcoming multipurpose and multi-product facility in Visakhapatnam, Andhra Pradesh.
 
The expansion plan includes increasing the capacity of derivatives of painkiller drug ibuprofen from current 180 tonne to 300 tonne and capacity of gabapentin from 420 tonne to 720 tonne. The capacity expansion is slated to be completed by September 2011. It has also undertaken formulation capacity expansion from 1.8 billion tablets to four billion tablets.
← All latest storiesBack to top →